InnoGene BioTech

Shanghai, China · Founded 2022 · Privately Held (backing)

Developer of green synthetic biological products. InnoGene BioTech is based in Shanghai, China and was founded in 2022. Its last reported valuation was $27 million in Dec 2022. It has raised $41.5 million.

Last reported valuation
$27.0M
Oct 2026
Priced at
—
Total raised
$41.5M
Last round
—

Who backs InnoGene BioTech?

9 investors
InvestorType
Hefei Industry Investment GroupVenture capital
Furong CapitalOther
Flyfot Ventures—
Fontus Capital—
Hangzhou Huaiji Investment—
Hongsheng Capital—
Hygeia Capital—
InnoPinnacle—
Zhangjiang Hi-Tech Investment—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

InnoGene BioTech investors

9 investors are on record for InnoGene BioTech, including Hefei Industry Investment Group, Furong Capital, Flyfot Ventures and Fontus Capital.

Free account
More of InnoGene BioTech with a free account
  • ·Watch InnoGene BioTech: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 9 firms already write checks for companies like InnoGene BioTech. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View